') no-repeat 50% 50%;mask:url('data:image/svg+xml,') no-repeat 50% 50%;-webkit-mask-size:cover;mask-size:cover;margin-left:.625rem;transform:rotate(0);transition:transform .1s}.dropdown-toggle:not([class*=btn-]):focus,.dropdown-toggle:not([class*=btn-]):hover{color:#2196f3;font-weight:500;background-color:inherit}.form-control{background-clip:border-box;-webkit-appearance:none;filter:none;border:1px solid #bbb;box-sizing:border-box;border-radius:5px;background-color:#fff;width:100%;height:auto;font-size:.875rem;font-weight:500;padding:.625rem .875rem;box-shadow:none}.form-control:-webkit-autofill,.form-control:-webkit-autofill:active,.form-control:-webkit-autofill:focus,.form-control:-webkit-autofill:hover{box-shadow:0 0 0 30px #fff inset!important}.form-control:disabled{color:#999;background-color:#f5f5f5}.form-control:focus,.form-control:focus-visible{box-shadow:none}.form-check-new{position:relative;display:flex}.form-check-new+.form-check-new{margin-top:.625rem}.form-check-new:not(.inline){margin-bottom:.25rem}.form-check-new:not(.inline)>xetf-checkbox{margin-right:.875rem}.text-check{line-height:1.5;font-size:.75rem;color:#444;padding-top:1px}.text-check.sm{font-size:.625rem;padding-top:2px}.text-check a{font-weight:600}.check-container{display:flex;align-items:center;margin-bottom:0;cursor:pointer}.check-container:not(.disabled):hover{color:#666}.check-container .checkbox,.check-container .checkbox input,.check-container .checkbox span{width:var(--checkbox-size);height:var(--checkbox-size)}.check-container .checkbox input{border:0;background:0 0;display:inline-block;margin:0;cursor:pointer;position:absolute;visibility:visible;opacity:0;z-index:2}.check-container .checkbox input:checked~span:after{opacity:1}.check-container .checkbox input:focus~span,.check-container .checkbox input:hover~span{box-shadow:0 4px 4px #0000001f}.check-container .checkbox span{border:calc(var(--checkbox-size) * .1) solid #999;display:inline-block;text-align:center;position:relative;color:#42a5f5;transition:box-shadow .15s ease-in-out}.check-container .checkbox span:after{content:"";position:absolute;opacity:0;transition:opacity .15s ease-in-out}.check-container .checkbox span:checked:after{opacity:1}[class*=bg-]:not(.bg-transparent):not(.bg-light):not(.bg-white):not(.btn-outline):not(body){color:#fff}.font-size-sm{font-size:.8125rem!important}.font-size-xs{font-size:.75rem!important}.font-size-larger{font-size:larger}.rotate-180{transform:rotate(180deg)}.w-100{width:100%!important}.hidden{visibility:hidden}.nowrap{white-space:nowrap}.input-group .input-group-prepend{z-index:4}.input-group:focus-within .input-group-prepend{border-color:#ccc}.input-group .input-group-prepend{position:absolute;top:0;height:2.7622rem;transition:border-color .15s ease-in-out,box-shadow .15s ease-in-out}.input-group .input-group-text{border:0;font-weight:500;transition:border-color .15s ease-in-out,box-shadow .15s ease-in-out}.input-group .input-group-text xetf-icon{color:#bbb;font-size:.9375rem}.input-group.with-append .form-control{padding-right:2.6875rem;border-top-right-radius:5px!important;border-bottom-right-radius:5px!important}.input-group .input-group-prepend{border-right-width:0;border-top-left-radius:5px;border-bottom-left-radius:5px}.input-group .input-group-prepend .input-group-text{padding-right:0}.input-group .input-group-prepend+.form-control{padding-left:2.6875rem;border-radius:5px!important}.input-group .form-control{font-size:.875rem}.input-group .form-control::placeholder{color:#aaa;font-weight:500}.input-group .form-control::-webkit-search-cancel-button{display:none}.input-group .form-control::-webkit-inner-spin-button,.input-group .form-control::-webkit-outer-spin-button{-webkit-appearance:none;margin:0}html{display:flex;flex-direction:column;scroll-behavior:smooth}body{min-height:100vh;display:flex;flex-direction:column;flex:1}.content{padding:1.25rem .625rem;flex-grow:1;z-index:1}app-root{transition:.15s ease-in}.nav-link{position:relative;transition:.15s ease-in-out}.nav-pills{margin-bottom:1.25rem}.nav-pills .nav-link{color:#777}.nav-pills .nav-link:not(.active):focus,.nav-pills .nav-link:not(.active):hover{color:#324148}.toolbar-container{display:flex;flex-wrap:wrap;position:relative}.toolbar-container .toolbar-main-items,.toolbar-container .toolbar-misc-items{height:40px}.toolbar-container .toolbar-main-items{position:static;overflow-x:auto;overflow-y:hidden;flex:1 0 100%}.toolbar-container .toolbar-main-items:after,.toolbar-container .toolbar-main-items:before{content:"";position:absolute;top:0;width:30px;height:40px;z-index:1;transition:box-shadow .3s;pointer-events:none}.toolbar-container .toolbar-main-items:before{left:0}.toolbar-container .toolbar-main-items:after{right:0}.toolbar-container .toolbar-main-items::-webkit-scrollbar{display:none}.toolbar-container .toolbar-misc-items{position:relative;display:flex;flex-wrap:nowrap;flex-grow:1}.toolbar-container .border-placeholder{position:absolute;left:0;right:0;top:38px;height:2px;background-color:#e5e5e5}.toolbar-container .nav-pills{justify-content:space-between;flex-wrap:nowrap;margin-bottom:0}.toolbar-container .nav-pills>:not(.separator){text-align:center;flex:1}.toolbar-container .dropdown-toggle:focus,.toolbar-container .dropdown-toggle:hover{font-weight:400!important}.toolbar-container .separator{position:relative}.toolbar-container .separator:after{content:"";position:absolute;height:14px;width:1px;right:1px;border-right:1px solid #c9c9c9;top:calc(50% - 7px)}.toolbar-container .nav-link{position:relative;white-space:nowrap;-webkit-user-select:none;user-select:none;line-height:20px;padding:10px 20px;color:#333;border-radius:0}.toolbar-container .nav-link:focus,.toolbar-container .nav-link:hover{color:#2196f3!important}.toolbar-container .nav-link.active{color:#2196f3!important;background-color:transparent!important}.toolbar-container .nav-link.active:after{content:"";position:absolute;bottom:0;left:0;right:0;height:4px;background-color:#2196f3;z-index:2}.navbar{font-size:.75rem;font-weight:600}.navbar .dropdown-menu,.navbar .navbar-nav-link{font-size:.75rem;white-space:nowrap}.navbar .nav-item>a{border-bottom:2px solid transparent}.navbar-brand img{height:1.625rem;display:block}@media (max-width:1199.98px){.navbar-brand img{height:1.25rem}}.navbar-nav{justify-content:space-evenly}.navbar-nav-link{position:relative;display:flex;cursor:pointer;padding:1rem;outline:0;transition:.15s ease-in-out}.navbar-toggler{border:0;cursor:pointer;padding-left:0;padding-right:0;transition:.15s ease-in-out}@media (max-width:1199.98px){.navbar-toggler{padding-top:.75rem;padding-bottom:.75rem}.navbar-expand-xl .navbar-nav-link{display:flex;align-items:center;margin-left:-1.5rem;margin-right:-1.5rem;padding-left:1.5rem;padding-right:1.5rem}}.navbar-dark{color:#fff;background-color:#324148}.navbar-dark .navbar-nav-link{color:#fff}.navbar-dark .navbar-nav-link:focus,.navbar-dark .navbar-nav-link:hover{color:#fff;background-color:#00000026}.table{margin-bottom:0;color:#324148}.table td,.table th{vertical-align:middle;padding-left:2px;padding-right:2px}.table th{font-weight:500}.table thead:first-child tr:first-child th{border-top-width:0}.table td,.table th,.table tr{transition:background-color .15s ease-in-out}.table tbody:first-child tr:first-child td,.table tbody:first-child tr:first-child th,div[class*=table-responsive]>.table tbody:first-child tr:first-child td,div[class*=table-responsive]>.table tbody:first-child tr:first-child th{border-top:0}h1,h2,h3{letter-spacing:-.015em}.list-inline-item{position:relative}.font-weight-semibold{font-weight:500!important}.text-default{color:#324148}a.text-default:not(.btn):not(.td_btn):not(.vc_btn){transition:color .15s ease-in-out}a.text-default:focus,a.text-default:hover{color:#324148bf}.profile-card h1{font-size:1.875rem;font-weight:700;margin-bottom:0;line-height:1}.profile-card .card-body{padding-bottom:0}.profile-card .profile-main-info{font-size:.825rem;flex-wrap:wrap;align-items:center}.profile-card .profile-main-info.with-bottom-space>*{margin-bottom:1.125rem}.profile-card .profile-main-info .badge{display:inline-block!important;font-size:.625rem}.profile-card .profile-main-info .badge.badge-light{padding-top:6px;padding-bottom:6px}.profile-card .separated-properties>span:not(:first-of-type):not(:empty):not(.badge):before{content:"|";color:#c9c9c9;font-size:1rem;margin-left:.25rem;margin-right:.25rem}.profile-card .separated-properties>span.badge:not(:last-child){margin-right:.625rem!important}.profile-card .nav-pills{margin-bottom:1.125rem}.profile-card .top-info{display:flex;flex-wrap:wrap;min-width:150px}.profile-card .top-info .top-info-column{position:relative;margin-bottom:1.125rem}.profile-card .top-info .top-info-column>.text-muted{display:flex;align-items:center;white-space:nowrap}.profile-card .top-info .top-info-column:not(:last-child){padding-right:1.25rem;margin-right:1.25rem}.profile-card .top-info .top-info-column:not(:last-child):after{content:"";position:absolute;height:14px;width:1px;right:1px;border-right:1px solid #c9c9c9;top:calc(50% - 7px);padding:0 1.25rem}.profile-card .top-info .value{font-size:.875rem;line-height:130%;font-weight:700}.profile-card .top-info .text-muted{font-size:.625rem}.profile-card .top-info .text-muted>xetf-icon{margin-left:.3125rem;color:#1976d2;padding-bottom:2px}.profile-card .provider-icon-wrapper{display:flex;align-items:center;margin-bottom:.625rem}@media (max-width:767.98px){.profile-card{margin-bottom:1rem}.profile-card h1{font-size:1.25rem}.profile-card .profile-main-info{font-size:.625rem}.profile-card .top-info.desktop-only{display:none}.profile-card .provider-icon-wrapper{align-items:flex-start}}.profile-card .provider-icon-wrapper .provider-logo{display:block;height:50px;min-width:50px;margin:auto 1.25rem auto 0;overflow:hidden}.profile-card .provider-icon-wrapper .investment-name-wrapper{display:flex;flex-direction:column}.profile-card .provider-icon-wrapper .investment-name-wrapper .investment-name{display:flex;flex-direction:row}.profile-card .toolbar-container{border-top:2px solid #e5e5e5}.profile-card .toolbar-container .toolbar-main-items{border-bottom-left-radius:5px}.profile-card .toolbar-container.with-misc-items .toolbar-main-items .nav-item .nav-link{padding-left:14px;padding-right:14px}@media (max-width:767.98px){.profile-card .provider-icon-wrapper .provider-logo{margin-top:0}.profile-card .toolbar-container.with-misc-items .toolbar-main-items .nav-item .nav-link{min-width:calc((100vw - 1.25rem)/ 3)}}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items{justify-content:space-evenly}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items>:not(.separator){padding-left:2rem;padding-right:2rem}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items xetf-icon{display:block}.profile-card .border-placeholder{display:none}.app-container{width:100%;margin:0 auto}.ordering-header,a{cursor:pointer}.table.last-column-right-aligned td:last-child,.table.last-column-right-aligned th:last-child{text-align:right}.selection-counter{color:#2196f3;font-weight:700;font-size:12px;margin-left:.625rem}.blurred{filter:blur(10px);-webkit-user-select:none;user-select:none}.auth-offer-container{position:relative;display:block;min-height:150px}.auth-offer{position:absolute;top:0;bottom:0;left:0;right:0;z-index:10;display:flex;flex-direction:column;align-items:center;font-size:1rem;font-weight:500;padding-top:50px}.real-time-course-wrapper{display:flex;align-items:center;justify-content:space-between;flex-wrap:wrap}.course-value{font-size:1.625rem;font-weight:700;margin-bottom:0;margin-right:1.5rem}.course-percentage{font-size:1rem;font-weight:700}.card-columns-ordered>*{page-break-inside:avoid!important;break-inside:avoid!important}
Die Regeneron Pharmaceuticals Inc Aktie ist bei insgesamt 5 Online Broker(n) sparplanfähig. Bei 5 Anbieter(n) davon ist die Regeneron Pharmaceuticals Inc Aktie aktuell kostenfrei im Sparplan erhältlich. Die Mindestsparrate beträgt 1 €.
Wichtige Kennzahlen und Stammdaten zur Regeneron Pharmaceuticals Inc Aktie.
Marktkapitalisierung | 71,49 Mrd. € |
KGV | 9,99 |
KBV | 3,57 |
KUV | 5,02 |
KCV | 8,57 |
Ausgegebene Aktien | 108 Mio. Stück |
Regeneron Pharmaceuticals Inc ist in folgendem Land registriert: Vereinigte Staaten (USA) (Börse: USNASD).
Hier siehst du die Wertentwicklung der Regeneron Pharmaceuticals Inc Aktie.
Zeitraum | Performance |
---|---|
1 Woche | +5,04 % |
1 Monat | -8,90 % |
3 Monate | +11,94 % |
6 Monate | +8,76 % |
1 Jahr | +46,02 % |
Lfd. Jahr | +8,08 % |
Mit einer (erwarteten) Jahresdividende von — ergibt sich zum aktuellen Kurs der Aktie eine Dividendenrendite von —.
Dividendenart | — |
(Erwartete) Jahresdividende | — |
Dividendenrendite | — |
Insgesamt haben 10 ETFs die Regeneron Pharmaceuticals Inc Aktie in ihren Top 10 Bestandteilen enthalten. Mit 7,40 % ist Regeneron Pharmaceuticals Inc das größte Gewicht im iShares Nasdaq US Biotechnology UCITS ETF.
ROUNDUP: GlaxoSmithKline-Antikörpercocktail in Labortests gegen Omikron aktiv
GlaxoSmithKline: Antikörpercocktail in ersten Labortests gegen Omikron aktiv
ROUNDUP 2: EMA macht Weg frei für zwei neue Covid-Medikamente
EU-Arzneimittelbehörde prüft Zulassung von Corona-Medikament
Roche erreicht mit Corona-Cocktail Ronapreve gesteckte Ziele in Studie
Stammdaten werden bereitgestellt von Morningstar (Aktien, ETFs, Fonds), CoinGecko (Kryptowährungen) und der Isarvest GmbH. Kursdaten sind mindestens 15 Minuten zeitverzögerte Börsenkurse (Aktien, ETFs, Fonds) oder NAV-Kurse (ETFs, Fonds). Realtime-Kurse – sofern verfügbar – stammen von den Anbietern und der Lang & Schwarz (Aktien, ETFs, Fonds) und CoinGecko (Kryptowährungen).
Die Isarvest GmbH übernimmt für die dargestellten Informationen keine Gewährleistung und kann nicht sicherstellen, dass die Daten vollständig und genau sind.